June 17, 2021
23andMe Successfully Closes its Business Combination with VG Acquisition Corp.
Combined Company to Trade on Nasdaq Under Ticker “ME” Commencing June 17SUNNYVALE, Calif. and NEW YORK, June 16, 2021 (GLOBE…
Pharmaceuticals, Biotechnology and Life Sciences
Combined Company to Trade on Nasdaq Under Ticker “ME” Commencing June 17SUNNYVALE, Calif. and NEW YORK, June 16, 2021 (GLOBE…
CAMBRIDGE, Mass., June 16, 2021 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) today announced topline results from its Phase 2 TANGO…
Transformative licensing agreement for treosulfan in the U.S. completed February 2, 2021 Cash and cash equivalents of $18.7 million and…
GAITHERSBURG, Md., June 16, 2021 (GLOBE NEWSWIRE) — NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to…
Dr. Slavin Brings Deep Clinical, Academic and Industry Experience to New RoleSALT LAKE CITY, June 16, 2021 (GLOBE NEWSWIRE) —…
DURHAM, N.C., June 16, 2021 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in…
– All three dose strengths of STS101, administered with improved 2nd-generation nasal delivery device were well-tolerated and achieved target pharmacokinetic…
More than 30 million Americans at risk for Lyme disease exposure, which can result in severe neurological and other debilitating…
CAMBRIDGE, Mass., June 16, 2021 (GLOBE NEWSWIRE) — Evelo Biosciences, Inc. (Nasdaq: EVLO), a clinical stage biotechnology company developing a…
STOUGHTON, Mass., June 16, 2021 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the…